Jiaying Luo

Dr. Jiaying Luo


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
JLJiaying Luo
Jiaying Luo
HCHuian Chen
Huian Chen
QZQiyong Zhang
Qiyong Zhang
XHXinyun Huang
Xinyun Huang
XQXu Qin
Xu Qin
Baoqing SunBaoqing Sun
Baoqing Sun
Luo J, et al. Allergy Asthma Immunol Res. 2022 Nov;14(6):713-729. https://doi.org/10.4168/aair.2022.14.6.713

1 May 2024 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
FWFeng Wang
Feng Wang
CMCui-Lian Mo
Cui-Lian Mo
MLMing Lu
Ming Lu
XDXiao-Long Deng
Xiao-Long Deng
JLJiaying Luo
Jiaying Luo
Background: Ground glass nodules (GGNs) in the lung are considered to be a high-risk factor of lung adenocarcinoma. Immediate surgery is not recommended for GGNs patients, and low-dose computed tomography (CT) is often used for observation and follow-up, which brings high psychological and economic burden to the patient. Methods: Three traditional Chinese medicine (TCM) prescriptions for the treatment of GGNs were found through database including PubMed, Google Scholar, and China National Knowledge Infrastructure (CNKI), Scopus and so on. The possible targets of the active ingredients of the TCM preparations and the gene targets of GGNs were screened out from Traditional Chinese Medicine Systems Pharmacology (TCMSP), UniProt and GeneCards. Network visualization was realized via STRING, Cytoscape 3.7.2, Evenn, DAVID and Hiplot. Finally, molecular docking Vina and PyMOL software were performed to further explore the possibility of drug-target interactions using PubChem compounds, protein data bank (PDB) database, Autodocktools and Autodock. Results: Three TCM preparations could target the same 13 potential therapeutic targets in GGNs. From network pharmacology, 14 signaling pathways, the functions of the significant targets, an effective ingredient in TCM prescriptions and its functions were obtained. Conclusions: Chinese herbal formulas containing quercetin could be a potential treatment for GGNs, targeting C-reactive protein (CRP), tumor necrosis factor (TNF), interferon gamma (IFN-γ), intercellular adhesion molecule 1 (ICAM-1), and vascular endothelial growth factor A (VEGFA) through the hypoxia-inducible factor 1 (HIF-1) pathway, mitogen-activated protein kinase (MAPK) signaling pathway, and leukocyte transendothelial migration.

19 October 2022 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
JLJiaying Luo
Jiaying Luo
HCHui-An Chen
Hui-An Chen
YFYuan-Yu Feng
Yuan-Yu Feng
YCYe-Peng Chen
Ye-Peng Chen
XLXiangCheng Lei
XiangCheng Lei
Baoqing SunBaoqing Sun
Baoqing Sun
Background. Eosinophils were common inflammatory cells involved in the occurrence and development of various inflammatory diseases. Multiple recent studies have pointed to the increasingly important role of eosinophils in respiratory diseases. This article aims to compare the expression differences of blood eosinophil counts between asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO). Methods. Patients with asthma, COPD, and ACO who were seen in the First Affiliated Hospital of Guangzhou Medical University from January 2012 to June 2019 were included. We collected information such as age, gender, diagnosis, the eosinophil counts from the medical records. Moreover, the levels of 10 cytokines in the plasma of each group were detected by using the Meso Scale Discovery method. Results. We included 9787 patients with asthma, 15806 patients with COPD, and 831 ACO patients. From our results, it can be first found that eosinophil levels were age-related in the three diseases (asthma and ACO: p < 0.001 ; COPD: P = 0.001 ); in asthma and COPD, the number of eosinophils in males was more significant than that in females (asthma: p < 0.001 ; COPD: p = 0.012 ). Second, asthma patients had higher blood eosinophil counts than those with COPD and ACO ( p < 0.001 ). Moreover, we found out that eosinophil levels were highly expressed in the stable group of all three diseases. Finally, we found that most cytokines in ACO patients showed a downward trend when the level of eosinophils was low, whereas the results were reversed in asthma patients; 7 cytokines had similar trends in COPD and ACO patients. Conclusions. In conclusion, eosinophils have their own unique endotypes in asthma, COPD, and ACO patients, which were reflected in the fluctuation of their levels and changes in cytokine secretion.

1 July 2020 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
HHHaisheng Hu
Haisheng Hu
CCChuanxu Cai
Chuanxu Cai
MXMingshan Xue
Mingshan Xue
JLJiaying Luo
Jiaying Luo
CLChenxi Liao
Chenxi Liao
Baoqing SunBaoqing Sun
Baoqing Sun
Objective: The aim of this study was to analyse the level of serum matrix metalloproteinases (MMPs) in atopic and non-atopic COPD patients, providing guidance for clinical practice and theory for atopic COPD. Methods: Blood samples from 50 adult male patients with COPD, including 17 atopic and 33 non-atopic patients, were submitted for detection of MMP8, MMP9, surfactant associated protein D (SPD), noradrenaline (NE), leukotriene (LT) B4, recombinant proteoglycan (PRG4), Phadiatop sIgE, and tIgE levels. Patients’ Modified Medical Research Council Dyspnea Scale (mMRC), COPD Assessment Test (CAT), pulmonary function test results, FeNO, blood cell ratio and induced sputum were collected. Results: The level of serum tIgE in patients with atopic COPD [1876.00 kU/l (760.50, 5347.00)] was significantly higher than in patients with non-atopic COPD [377.00 kU/l (93.50, 581.50), P < 0.001]. The MMP8 levels in atopic COPD (1600 ± 1181 ng/mL) were significantly higher than in non-atopic COPD (973.3 ± 921.5 ng/mL, P = 0.0494), but there was no significant difference in MMP9, SPD, NE, LTB4, and PRG4 levels between the two groups. In atopic COPD patients, the rate of leukocyte (rs = 0.63, P < 0.001) and neutrophil (rs = 0.54, P < 0.05) were positively correlated with MMP8 levels, while lymphocyte rate was negatively correlated with MMP8 (rs = − 0.70, P < 0.001) and MMP9 levels (rs = − 0.54, P < 0.05). Optimal scale analysis showed that NE was most closely related to the basophil rate from induced sputum and FeNO levels (Cronbach’s alpha = 85.1%). Interestingly, all atopic COPD patients with mMRC ≥ 2, CAT ≥ 10, and CCQ ≥ 16 exhibited MMP8 levels > 1000 ng/mL. Conclusion: In general, tIgE and MMP8 levels were higher in atopic COPD patients than in non-atopic patients. NE levels were closely correlated with the basophil rate of induced sputum and FeNO levels, which may play an important role in the pathogenesis and development of atopic COPD.

1 December 2024 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
GWGuo-Feng Wu
Guo-Feng Wu
RCRong-Chao Chen
Rong-Chao Chen
JLJing Luo
Jing Luo
MLMing-Tai Li
Ming-Tai Li
PYPei Yu
Pei Yu
YQYin-Yin Qin
Yin-Yin Qin
Background: Currently, traditional blood biomarkers such as neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA) etc. are mostly elevated in the late stage of tumour, and patients have already lost the chance of tumour eradication when the relevant indexes are found to be elevated. Therefore, there is a need for blood biomarkers with higher sensitivity, better specificity, and better accessibility. Folate receptor-positive circulating tumor cells (FR+CTCs) may have diagnostic value in lung cancer. Nevertheless, there is a scarcity of research exploring the efficacy of FR+CTCs in screening pulmonary nodules for lung cancer. The aims of this study were to differentiate between lung cancer and benign pulmonary nodules using FR+CTCs in conjunction with blood markers and to develop a composite diagnostic model for pulmonary nodules. Methods: Based on the inclusion and exclusion guidelines, we retrospectively analysed 1,135 patients with pulmonary nodules who underwent tissue biopsy or surgical resection after FR+CTC testing, assessed the histopathological findings by a specialised pathologist, and collected and compared demographic characteristics, blood markers, imaging and pathological parameters in malignant and benign patients. The random forest model was used to screen for indicators and to establish a composite index of blood biomarkers. The performance of single factors or the integrated model were estimated by applying receiver operating characteristic (ROC) analysis. Results: A total of 612 patients were included in the lung cancer group, predominantly presenting with stage I adenocarcinomas (n=458). The median age was 54 years, and 43.1% of the patients were male. In comparison, 523 patients were included in the benign pulmonary nodules group, with a median age of 53 years and 46.8% male. No significant differences were identified between the two groups with regard to gender or age (P>0.05). The level of FR+CTCs in the lung cancer group was significantly higher than that in the benign nodule group (P<0.001). The white blood cell (WBC) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) levels were significantly higher in the lung cancer group than in the benign nodule group (P<0.001 and P=0.01, respectively). FR+CTC level was associated with the pathological subtype (P=0.02), WBC (P<0.001), and lactate dehydrogenase (LDH) level (P=0.01). In both groups, the FR+CTC level was higher in the single-nodule group than in the multiple-nodule group (P=0.002 and P=0.040, respectively). The diagnostic sensitivity and specificity of FR+CTCs for lung cancer at a cutoff of 8.7 FU/3 mL was 61.9% and 75.0%, respectively. Increasing the cutoff to 1.5 times (13.1 FU/3 mL) and 2 times (17.4 FU/3 mL) improved the specificity to 90.8% and 95.6%, respectively. The combination of FR+CTCs with WBC, procalcitonin, and LDH resulted in an area under the curve of 0.976 [95% confidence interval (CI): 0.910–1.000], a sensitivity of 100.0%, and a specificity of 85.7%. Conclusions: FR+CTC was proven to be a viable blood biomarker for aiding in the early detection of lung cancer. The combined model based on FR+CTC showed substantially greater accuracy than did any single biomarker in patients with pulmonary nodules.

1 September 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
HCHuian Chen
Huian Chen
YXYongqing Xu
Yongqing Xu
XDXiaolong Deng
Xiaolong Deng
HCHaoqing Chen
Haoqing Chen
GYGuanyu Yan
Guanyu Yan
JLJiaying Luo
Jiaying Luo
Background: San-Feng-Tong-Qiao-Di-Wan (SFTQDW) is a patented compound Chinese medicine used for acute and chronic rhinitis with few side effects. Its key components have antiallergic activity, making it potentially suitable for allergic rhinitis (AR). However, there is a lack of systematic research on its efficacy and mechanism of action for AR. This study aims to evaluate the potential and mechanism of SFTQDW in treating AR using network pharmacology, AR animal models, clinical observation, and serum metabolomics. Methods: Network pharmacology was used to screen active ingredients and targets, followed by an AR mouse model study comparing SFTQDW 3.00 vs. 1.45 mg/g body weight vs. control. In a clinical substudy nested within an active-controlled trial, 35 AR patients received a 7-day SFTQDW treatment. Patient efficacy was assessed using Visual Analog Scale (VAS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and Epworth Sleepiness Scale (ESS) before and after treatment. Metabolic pathways and inflammatory responses were analyzed through serum metabolomics pre- and post-treatment. Results: SFTQDW was found to target 16 allergy-related proteins in network pharmacology analysis. In an OVA-mouse model, the 3.00 mg/g dose of SFTQDW reduced sneezing frequency, nasal-rubbing bouts, serum immunoglobulin E (IgE) levels, nasal-tissue eosinophil counts, and goblet-cell hyperplasia more effectively than the 1.45 mg/g dose. In a clinical study with 32 adults, oral SFTQDW for 7 days improved VAS, RQLQ, and ESS scores. Serum metabolomics revealed 27 differentiated metabolites, with effects on linoleic acid metabolism and aminoacyl-tRNA biosynthesis. Conclusions: By possibly modulating the PTGS2/5(S)-HETE axis and its associated lipid inflammatory metabolites, SFTQDW helped alleviate nasal inflammation and acute symptoms in mice and patients.